XNAS:F:F-Xtrackers NASDAQ 100 UCITS ETF 1C EUR (EUR)

ETF | Others |

Last Closing

USD 39.265

Change

+0.07 (+0.18)%

Market Cap

USD 0.67B

Volume

13.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.11 (+0.40%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.47%)

USD 116.66B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.24 (+0.44%)

USD 91.05B
SXR8:F iShares Core S&P 500 UCITS ETF..

-4.72 (-0.92%)

USD 85.22B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.11 (+0.49%)

USD 74.74B
EUNL:F iShares Core MSCI World UCITS ..

-0.51 (-0.56%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.20 (-0.09%)

USD 55.89B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.06 (+0.38%)

USD 55.84B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.80 (-0.88%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.63 (-0.68%)

USD 51.63B

ETFs Containing XNAS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.23% 76% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.23% 74% C 63% D
Trailing 12 Months  
Capital Gain 36.48% 91% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.48% 89% A- 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.74% 93% A 83% B
Dividend Return 14.74% 93% A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.77% 27% F 64% D
Risk Adjusted Return 82.92% 94% A 94% A
Market Capitalization 0.67B 66% D+ 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.